A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

400,000

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2030

Conditions
Breast Cancer ScreeningArtificial Intelligence (AI)
Interventions
DEVICE

Artificial intelligence (AI) decision-support tool

"The intervention is an AI decision-support tool to help radiologists interpret 3D screening mammograms. For exams randomized to this intervention arm, the first image displayed to the radiologist upon opening an exam on the viewing station will be a one-page, standardized AI report showing the overall exam risk (elevated, intermediate, or low), image region markings, lesion scores from 1-100 (100 being the highest suspicion), bounding boxes, and relevant slice locations for 3D exams. Radiologists can toggle markings on/off and retain full control over the final interpretation of the exam as positive or negative (i.e., they can choose to ignore the AI information).~Randomization occurs 1:1 at the exam level via automated code at image acquisition. Returning patients in year two will be re-randomized. Radiologists cannot filter their exam lists by AI availability or risk, and randomization will be independently managed at each participating health system."

Trial Locations (6)

33136

RECRUITING

University of Miami Health System, Miami

53706

RECRUITING

University of Wisconsin-Madison, Madison

90024

RECRUITING

University of California Los Angeles Health System, Los Angeles

92093

RECRUITING

University of California, San Diego, San Diego

98195

RECRUITING

University of Washington Health System, Seattle

02118

RECRUITING

Boston Medical Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

Boston Medical Center

OTHER

collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

University of Washington

OTHER

collaborator

California Breast Cancer Research Program

OTHER

collaborator

University of Miami

OTHER

collaborator

University of California, Davis

OTHER

lead

Jonsson Comprehensive Cancer Center

OTHER